To address this knowledge gap, we performed immunohistochemical analysis using clinically obtained lung adenocarcinoma (LUAD) and hepatocellular carcinoma (HCC) samples to comparatively evaluate GPR141 expression patterns between normal and tumor tissues. This evidence concerns the gene GPR141 and lung adenocarcinoma.